Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Early Outcomes of Sutureless Aortic Valves

  • Hanedan, Muhammet Onur (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Mataraci, Ilker (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Yuruk, Mehmet Ali (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Ozer, Tanil (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Sayar, Ufuk (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Arslan, Ali Kemal (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Ziyrek, Ugur (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital) ;
  • Yucel, Murat (Department of Cardiovascular Surgery, Ahi Evren Thorax Cardiovascular Surgery Education and Research Hospital)
  • Received : 2015.11.09
  • Accepted : 2016.02.12
  • Published : 2016.06.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: In elderly high-risk surgical patients, sutureless aortic valve replacement (AVR) should be an alternative to standard AVR. The potential advantages of sutureless aortic prostheses include reducing cross-clamping and cardiopulmonary bypass (CPB) time and facilitating minimally invasive surgery and complex cardiac interventions, while maintaining satisfactory hemodynamic outcomes and low rates of paravalvular leakage. The current study reports our single-center experience regarding the early outcomes of sutureless aortic valve implantation. Methods: Between October 2012 and June 2015, 65 patients scheduled for surgical valve replacement with symptomatic aortic valve disease and New York Heart Association function of class II or higher were included to this study. Perceval S (Sorin Biomedica Cardio Srl, Sallugia, Italy) and Edwards Intuity (Edwards Lifesciences, Irvine, CA, USA) valves were used. Results: The mean age of the patients was $71.15{\pm}8.60years$. Forty-four patients (67.7%) were female. The average preoperative left ventricular ejection fraction was $56.9{\pm}9.93$. The CPB time was $96.51{\pm}41.27minutes$ and the cross-clamping time was $60.85{\pm}27.08minutes$. The intubation time was $8.95{\pm}4.19hours$, and the intensive care unit and hospital stays were $2.89{\pm}1.42days$ and $7.86{\pm}1.42days$, respectively. The mean quantity of drainage from chest tubes was $407.69{\pm}149.28mL$. The hospital mortality rate was 3.1%. A total of five patients (7.69%) died during follow-up. The mean follow-up time was $687.24{\pm}24.76days$. The one-year survival rate was over 90%. Conclusion: In the last few years, several models of valvular sutureless bioprostheses have been developed. The present study evaluating the single-center early outcomes of sutureless aortic valve implantation presents the results of an innovative surgical technique, finding that it resulted in appropriate hemodynamic conditions with acceptable ischemic time.

Keywords

References

  1. Santarpino G, Pfeiffer S, Schmidt J, Concistre G, Fischlein T. Sutureless aortic valve replacement: first-year single-center experience. Ann Thorac Surg 2012;94:504-8. https://doi.org/10.1016/j.athoracsur.2012.04.024
  2. Altintas G, Diken AI, Hanedan O, et al. The Sorin Freedom SOLO stentless tissue valve: early outcomes after aortic valve replacement. Tex Heart Inst J 2013;40:50-5.
  3. Pollari F, Santarpino G, Dell'Aquila AM, et al. Better short-term outcome by using sutureless valves: a propensity-matched score analysis. Ann Thorac Surg 2014;98:611-6. https://doi.org/10.1016/j.athoracsur.2014.04.072
  4. Folliguet TA, Laborde F, Zannis K, Ghorayeb G, Haverich A, Shrestha M. Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg 2012;93: 1483-8. https://doi.org/10.1016/j.athoracsur.2012.01.071
  5. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011;32:198-204. https://doi.org/10.1093/eurheartj/ehq339
  6. Phan K, Tsai YC, Niranjan N, et al. Sutureless aortic valve replacement: a systematic review and meta-analysis. Ann Cardiothorac Surg 2015;4:100-11.
  7. Eichstaedt HC, Easo J, Harle T, Dapunt OE. Early single-center experience in sutureless aortic valve implantation in 120 patients. J Thorac Cardiovasc Surg 2014;147:370-5. https://doi.org/10.1016/j.jtcvs.2012.12.062
  8. Breitenbach I, Wimmer-Greinecker G, Bockeria LA, et al. Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience. J Thorac Cardiovasc Surg 2010;140:878-84, 884.e1. https://doi.org/10.1016/j.jtcvs.2010.06.042
  9. Chalmers J, Pullan M, Mediratta N, Poullis M. A need for speed?: bypass time and outcomes after isolated aortic valve replacement surgery. Interact Cardiovasc Thorac Surg 2014;19:21-6. https://doi.org/10.1093/icvts/ivu102
  10. Ranucci M, Frigiola A, Menicanti L, Castelvecchio S, de Vincentiis C, Pistuddi V. Aortic cross-clamp time, new prostheses, and outcome in aortic valve replacement. J Heart Valve Dis 2012;21:732-9.
  11. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg 2010;38 Suppl:S1-S52. https://doi.org/10.1016/j.ejcts.2010.08.019
  12. Choi JB, Kim JH, Park HK, et al. Aortic valve replacement using continuous suture technique in patients with aortic valve disease. Korean J Thorac Cardiovasc Surg 2013;46:249-55. https://doi.org/10.5090/kjtcs.2013.46.4.249
  13. Di Eusanio M, Phan K. Sutureless aortic valve replacement. Ann Cardiothorac Surg 2015;4:123-30.
  14. Minh TH, Mazine A, Bouhout I, et al. Expanding the indication for sutureless aortic valve replacement to patients with mitral disease. J Thorac Cardiovasc Surg 2014;148:1354-9. https://doi.org/10.1016/j.jtcvs.2013.12.061
  15. Borger MA, Moustafine V, Conradi L, et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg 2015;99:17-25. https://doi.org/10.1016/j.athoracsur.2014.09.022
  16. Di Eusanio M, Fortuna D, De Palma R, et al. Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg 2011;141:940-7. https://doi.org/10.1016/j.jtcvs.2010.05.044
  17. Mazine A, Teoh K, Bouhout I, et al. Sutureless aortic valve replacement: a Canadian multicentre study. Can J Cardiol 2015;31:63-8. https://doi.org/10.1016/j.cjca.2014.10.030

Cited by

  1. Sutureless versus Conventional Aortic Valve Replacement: Outcomes in 70 High-Risk Patients Undergoing Concomitant Cardiac Procedures vol.45, pp.1, 2016, https://doi.org/10.14503/thij-16-6092
  2. Risk Factors for Postoperative Pacemaker Implantation After Rapid Deployment Aortic Valve Replacement: Results from the RADAR Registry vol.38, pp.4, 2016, https://doi.org/10.1007/s12325-021-01622-z
  3. Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves vol.111, pp.6, 2021, https://doi.org/10.1016/j.athoracsur.2020.07.034